A Review of Treatment Methods Focusing on Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation for Chronic Spinal Cord Injury
Overview
Affiliations
Cell transplantation therapy using human induced pluripotent stem cell-derived neural stem/progenitor cells (hiPSC-NS/PCs) has attracted attention as a regenerative therapy for spinal cord injury (SCI), and its efficacy in treating the subacute phase of SCI has been reported in numerous studies. However, few studies have focused on treatment in the chronic phase, which accounts for many patients, suggesting that there are factors that are difficult to overcome in the treatment of chronic SCI. The search for therapeutic strategies that focus on chronic SCI is fraught with challenges, and the combination of different therapies is thought to be the key to a solution. In addition, many issues remain to be addressed, including the investigation of therapeutic approaches for more severe injury models of chronic SCI and the acquisition of practical motor function. This review summarizes the current progress in regenerative therapy for SCI and discusses the prospects for regenerative medicine, particularly in animal models of chronic SCI.
Induced Neural Stem Cell Transplantation in Spinal Cord Injury: Present Status and Next Steps.
Jung J, Jeong J, Ko M, Lee B, Kwon W, Jeon S Korean J Neurotrauma. 2025; 20(4):234-245.
PMID: 39803345 PMC: 11711022. DOI: 10.13004/kjnt.2024.20.e45.
Vidman S, Ma Y, Fullenkamp N, Plant G Neural Regen Res. 2024; 20(11):3063-3075.
PMID: 39715081 PMC: 11881715. DOI: 10.4103/NRR.NRR-D-24-00901.
Cell therapy for neurological disorders.
Svendsen S, Svendsen C Nat Med. 2024; 30(10):2756-2770.
PMID: 39407034 DOI: 10.1038/s41591-024-03281-3.
Winn D, Uhlin E, Kele M, Eidhof I, Falk A Front Pharmacol. 2024; 15:1390058.
PMID: 38841365 PMC: 11150580. DOI: 10.3389/fphar.2024.1390058.
Human stem cell transplantation models of Alzheimer's disease.
Ifediora N, Canoll P, Hargus G Front Aging Neurosci. 2024; 16:1354164.
PMID: 38450383 PMC: 10915253. DOI: 10.3389/fnagi.2024.1354164.